CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 19 enrolled
Drug / intervention
Hydrocortisone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03302416
NCT03302416Early Ph 1Completed
CompareCT.gov

In Vivo Imaging of Corticotropin-releasing Factor - Nociceptin Receptor Interactions

University of Pittsburgh·interventional·Posted Oct 5, 2017·Updated Oct 27, 2020

In Brief

A Early Phase 1 clinical trial evaluating Hydrocortisone and [C-11]NOP-1A for Healthy. Completed, enrolled 19 participants across 1 site.

Detailed Summary

To determine if \[C-11\]NOP-1A receptor binding (VT) can be altered by an intravenous hydrocortisone (cortisol) challenge through CRF-NOP interactions

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Early Ph 1CompletedFinished
2017201820192020202120222023202420252026
First PostedOct 5, 2017
Enrollment StartJun 1, 2016
Primary CompletionJun 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 8.7 years ago

Interventions

Hydrocortisonedrug

[C-11]NOP-1Aradiation